Literature DB >> 11007801

Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain.

A S Hackam1, A S Yassa, R Singaraja, M Metzler, C A Gutekunst, L Gan, S Warby, C L Wellington, J Vaillancourt, N Chen, F G Gervais, L Raymond, D W Nicholson, M R Hayden.   

Abstract

Huntington disease is a devastating neurodegenerative disease caused by the expansion of a polymorphic glutamine tract in huntingtin. The huntingtin interacting protein (HIP-1) was identified by its altered interaction with mutant huntingtin. However, the function of HIP-1 was not known. In this study, we identify HIP-1 as a proapoptotic protein. Overexpression of HIP-1 resulted in rapid caspase 3-dependent cell death. Bioinformatics analyses identified a novel domain in HIP-1 with homology to death effector domains (DEDs) present in proteins involved in apoptosis. Expression of the HIP-1 DED alone resulted in cell death indistinguishable from HIP-1, indicating that the DED is responsible for HIP-1 toxicity. Furthermore, substitution of a conserved hydrophobic phenylalanine residue within the HIP-1 DED at position 398 eliminated HIP-1 toxicity entirely. HIP-1 activity was found to be independent of the DED-containing caspase 8 but was significantly inhibited by the antiapoptotic protein Bcl-x(L), implicating the intrinsic pathway of apoptosis in HIP-1-induced cell death. Co-expression of a normal huntingtin fragment capable of binding HIP-1 significantly reduced cell death. Our data identify HIP-1 as a novel proapoptotic mediator and suggest that HIP-1 may be a molecular accomplice in the pathogenesis of Huntington disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007801     DOI: 10.1074/jbc.M008408200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Huntington's disease.

Authors:  S Davies; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

2.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

3.  Crystal structure at 2.8 A of the DLLRKN-containing coiled-coil domain of huntingtin-interacting protein 1 (HIP1) reveals a surface suitable for clathrin light chain binding.

Authors:  Joel A Ybe; Sanjay Mishra; Stephen Helms; Jay Nix
Journal:  J Mol Biol       Date:  2006-12-23       Impact factor: 5.469

4.  Crystal structure at 2.8 A of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain reveals a charged surface suitable for HIP1 protein interactor (HIPPI).

Authors:  Qian Niu; Joel A Ybe
Journal:  J Mol Biol       Date:  2007-11-22       Impact factor: 5.469

5.  Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.

Authors:  Paula A Desplats; James R Lambert; Elizabeth A Thomas
Journal:  Neurobiol Dis       Date:  2008-05-22       Impact factor: 5.996

Review 6.  Unconventional functions for clathrin, ESCRTs, and other endocytic regulators in the cytoskeleton, cell cycle, nucleus, and beyond: links to human disease.

Authors:  Frances M Brodsky; R Thomas Sosa; Joel A Ybe; Theresa J O'Halloran
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-02       Impact factor: 10.005

7.  Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.

Authors:  Dinesh S Rao; Teresa S Hyun; Priti D Kumar; Ikuko F Mizukami; Mark A Rubin; Peter C Lucas; Martin G Sanda; Theodora S Ross
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors.

Authors:  D S Rao; J C Chang; P D Kumar; I Mizukami; G M Smithson; S V Bradley; A F Parlow; T S Ross
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

9.  Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell death.

Authors:  David Engelmann; Susanne Knoll; Daniel Ewerth; Marc Steder; Anja Stoll; Brigitte M Pützer
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

10.  Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.

Authors:  Chiron W Graves; Steven T Philips; Sarah V Bradley; Katherine I Oravecz-Wilson; Lina Li; Alice Gauvin; Theodora S Ross
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.